Seng EK, Singer AB, Metts C, et al. - Researchers conducted the current phase 2b study investigating the efficacy of mindfulness-based cognitive therapy for migraine (MBCT-M) in decreasing migraine-related disability in people with migraine. In MBCT, mindfulness meditation and cognitive-behavioral skills are taught and these skills are directly applied to address disease-related cognitions. They randomized 60 participants with migraine (6-30 headache days/month) to receive MBCT-M (n = 31) or waitlist/treatment as usual (n = 29). The MBCT-M group showed more reduction in the headache disability inventory mean scores from month 0 to month 4 (−14.3) than the waitlist/treatment as a usual group (−0.2). In addition, the MBCT-M group indicated a decrease in mean Migraine Disability Index scores (−0.6/10), whereas the waitlist/treatment as a usual group had an increase in these scored (+0.3/10). These findings support the efficacy of MBCT-M in reducing headache-related disability and attack-level migraine-related disability. MBCT-M was thus supported as a promising emerging treatment for addressing migraine-related disability.